RFK Jr.’s CDC Panel: Vaccine Evidence Under Review
Robert F. Kennedy Jr.’s newly formed advisory panel is intensely scrutinizing COVID-19 mRNA vaccines, raising critical questions about their efficacy. The panel, part of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), is also debating the merits of RSV immunization for infants.Expect robust discussions on established vaccines, including those for hepatitis B and measles. The panel’s mandate centers on evidence-based medicine, sparking lively debate on vaccine safety. Stay informed with News Directory 3.Discover what’s next in this evolving area of public health.
Kennedy’s Vaccine Panel Questions COVID Shots, RSV Immunization Debated
Updated June 29, 2025
A newly appointed panel of federal vaccine advisers, selected by Health and Human Services Secretary Robert F. Kennedy Jr., convened Wednesday to review vaccine recommendations.The panel’s formation follows the dismissal of its predecessor earlier in June.
While no votes were cast, the group intensely examined the evidence behind COVID-19 vaccines and indicated they would also review other established vaccines, including those for hepatitis B and measles. the panel is part of the Centers for disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP).
Martin Kulldorff, a biostatistician and epidemiologist now chairing the ACIP panel, stated the committee’s mandate is to use evidence-based medicine for vaccine recommendations. “Vaccines are not all good or bad,” Kulldorff said.”If you think that all vaccines are safe and effective and want them all, or if you think that all vaccines are dangerous and don’t want any of them, then you don’t have much use for us.”
Kulldorff previously testified against Merck &